The coalition’s cancer muddle

Previously when a cancer drug was put to NICE for appraisal there was a strong incentive for the drug company to offer a decent NHS-wide price that might be accepted as value for money. Indeed NHS drug prices are generally very competitive.

The quangos start to burn

The government has lit the touch paper to start the ‘bonfire of the quangos’ today in announcing that it will axe nearly 200 quangos, reports Katy Mughan.